.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
McKinsey
Johnson and Johnson
Colorcon
QuintilesIMS
Citi
Cerilliant
McKesson
Queensland Health

Generated: December 14, 2017

DrugPatentWatch Database Preview

Patents Expiring in June 2032

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Chemo Research SlNUVESSAmetronidazoleGEL;VAGINAL205223-001Mar 24, 2014RXYesYes► Subscribe► Subscribe► SubscribeTREATMENT OF BACTERIAL VAGINOSIS WITH METRONIDAZOLE GEL
Neos TherapsADZENYS XR-ODTamphetamineTABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL204326-006Jan 27, 2016RXYesYes► Subscribe► Subscribe► SubscribeY
Neos TherapsADZENYS XR-ODTamphetamineTABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL204326-003Jan 27, 2016RXYesNo► Subscribe► Subscribe► SubscribeY
Neos TherapsADZENYS XR-ODTamphetamineTABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL204326-006Jan 27, 2016RXYesYes► Subscribe► Subscribe► SubscribeY
Chemo Research SlNUVESSAmetronidazoleGEL;VAGINAL205223-001Mar 24, 2014RXYesYes► Subscribe► Subscribe► SubscribeTREATMENT OF BACTERIAL VAGINOSIS WITH METRONIDAZOLE GEL
Neos TherapsADZENYS XR-ODTamphetamineTABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL204326-006Jan 27, 2016RXYesYes► Subscribe► Subscribe► SubscribeY
Neos TherapsADZENYS XR-ODTamphetamineTABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL204326-003Jan 27, 2016RXYesNo► Subscribe► Subscribe► SubscribeY
Neos TherapsADZENYS XR-ODTamphetamineTABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL204326-001Jan 27, 2016RXYesNo► Subscribe► Subscribe► SubscribeY
Neos Theraps IncCOTEMPLA XR-ODTmethylphenidateTABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL205489-001Jun 19, 2017RXYesNo► Subscribe► Subscribe► SubscribeY
Neos TherapsADZENYS XR-ODTamphetamineTABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL204326-004Jan 27, 2016RXYesNo► Subscribe► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Queensland Health
Healthtrust
Harvard Business School
Express Scripts
Chinese Patent Office
Merck
US Army
McKinsey
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot